Non-Invasive Liver Fibrosis Assessment Using Shock Wave Technology - Gastroenterology and Hepatology

More Info

---

Non-invasive liver fibrosis assessment using shock wave technology, often referred to as transient elastography or FibroScan, has gained traction as a reliable method for evaluating liver stiffness, which correlates with the degree of liver fibrosis. This technique utilizes ultrasound-based technology to measure the elasticity of liver tissue, providing a quantitative assessment without the need for invasive procedures like liver biopsy.

In Taiwan, this technology is indeed available, and several medical institutions have adopted it to aid in the diagnosis and monitoring of liver conditions, including fibrosis and cirrhosis. Specifically, hospitals such as Chang Gung Memorial Hospital in Kaohsiung offer this service. Patients can undergo the FibroScan procedure as a self-paying service, which is not covered by national health insurance. This makes it accessible for those seeking to understand their liver health without the discomfort and risks associated with a liver biopsy.

The results from a FibroScan are expressed in kilopascals (kPa), with lower values typically indicating less fibrosis. For instance, a stiffness measurement of less than 7.1 kPa generally suggests that there is no significant fibrosis or bridging necrosis, while higher values may indicate more advanced fibrosis or cirrhosis. It is important to note that while FibroScan is a valuable tool, it should be interpreted in conjunction with other clinical findings, including blood tests and imaging studies, to provide a comprehensive assessment of liver health.

In terms of where to get this test done, patients in Kaohsiung can visit the gastroenterology department at Chang Gung Memorial Hospital or other facilities that offer FibroScan services. It is advisable to call ahead and confirm the availability of the test and whether an appointment is necessary.

Furthermore, while FibroScan is a non-invasive method, it is not without limitations. Factors such as obesity, ascites, and the presence of other liver diseases can affect the accuracy of the results. Therefore, it is crucial for patients to discuss their individual circumstances with their healthcare provider to determine the most appropriate diagnostic approach.

In summary, non-invasive liver fibrosis assessment using shock wave technology is available in Taiwan, including in Kaohsiung. Patients interested in this assessment should consult with their healthcare provider to discuss the potential benefits and limitations of the test, as well as to explore the best options for monitoring their liver health. Regular follow-up and comprehensive evaluation remain essential components of managing liver conditions effectively.